Cubist Systematic Strategies LLC Makes New $7.44 Million Investment in Integral Ad Science Holding Corp. $IAS

Key Points

• Cubist Systematic Strategies LLC acquired 923,168 shares of Integral Ad Science Holding Corp., valued at approximately $7.44 million, representing around 0.56% ownership in the company.
• Integral Ad Science reported earnings of $0.07 per share for the last quarter, exceeding analysts' estimates, with a revenue of $149.20 million.
• Institutional investors and hedge funds collectively own 95.78% of Integral Ad Science's stock, indicating strong institutional interest in the company.

Cubist Systematic Strategies LLC bought a new position in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 923,168 shares of the company's stock, valued at approximately $7,441,000. Cubist Systematic Strategies LLC owned approximately 0.56% of Integral Ad Science as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of Integral Ad Science by 0.5% in the first quarter. Vanguard Group Inc. now owns 9,090,229 shares of the company's stock worth $73,267,000 after purchasing an additional 41,683 shares in the last quarter. Sunriver Management LLC increased its position in Integral Ad Science by 12.0% during the 1st quarter. Sunriver Management LLC now owns 8,166,774 shares of the company's stock valued at $65,824,000 after purchasing an additional 875,740 shares during the period. Aberdeen Group plc increased its position in Integral Ad Science by 12.7% during the 1st quarter. Aberdeen Group plc now owns 1,994,980 shares of the company's stock valued at $16,080,000 after purchasing an additional 224,153 shares during the period. Nuveen Asset Management LLC increased its position in Integral Ad Science by 0.8% during the 4th quarter. Nuveen Asset Management LLC now owns 1,920,523 shares of the company's stock valued at $20,050,000 after purchasing an additional 15,432 shares during the period. Finally, Nuveen LLC purchased a new position in Integral Ad Science during the 1st quarter valued at $10,897,000. Hedge funds and other institutional investors own 95.78% of the company's stock.

Insider Buying and Selling at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 14,904 shares of the stock in a transaction that occurred on Tuesday, July 8th. The shares were sold at an average price of $8.31, for a total value of $123,852.24. Following the transaction, the chief executive officer owned 379,316 shares in the company, valued at $3,152,115.96. This represents a 3.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In the last quarter, insiders have sold 35,073 shares of company stock valued at $289,641. 2.00% of the stock is owned by corporate insiders.

Integral Ad Science Stock Up 0.4%

IAS traded up $0.03 during midday trading on Monday, hitting $8.75. 161,723 shares of the company traded hands, compared to its average volume of 1,006,907. The firm has a market capitalization of $1.45 billion, a PE ratio of 25.75, a price-to-earnings-growth ratio of 1.24 and a beta of 1.57. The company's 50-day moving average is $8.54 and its 200 day moving average is $8.29. Integral Ad Science Holding Corp. has a 52 week low of $6.26 and a 52 week high of $13.62.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.03. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. The business had revenue of $149.20 million for the quarter, compared to analysts' expectations of $143.02 million. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, sell-side analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on IAS shares. Raymond James Financial reduced their price objective on shares of Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating on the stock in a research report on Friday, August 8th. Stifel Nicolaus upped their target price on shares of Integral Ad Science from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Tuesday, July 22nd. Wall Street Zen raised shares of Integral Ad Science from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Finally, Barclays increased their price objective on shares of Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a research report on Friday, August 8th. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, Integral Ad Science currently has a consensus rating of "Moderate Buy" and a consensus target price of $13.55.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.